Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase

13Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: All neoplastic cells express one or more members of a unique family of tumor-associated cell surface ubiquinone (NADH) oxidase proteins with protein disulfide-thiol interchange activity (ENOX2 or tNOX proteins) that are characteristically blocked by quinone site inhibitors with anti-cancer activity. Methods: Analyses using two-dimensional gel electrophoresis with detection on western blots using a pan ENOX2 recombinant antibody revealed unique ENOX2 isoforms or unique combinations of isoforms of differing molecular weights and/or isoelectric points in sera of patients with cancers of different cellular or tissue origins. Results and Discussion: Isoform presence provides for broad-range cancer detection. The specific patterns and molecular weights of the isoforms present allows for identification of the cell type and/or tissue of origin of the neoplasm. ENOX2 isoform presence and relative amounts are largely independent of stage but may be proportional to tumor burden to provide indications of response to therapy and disease progression. © 2008 Humana Press.

Cite

CITATION STYLE

APA

Hostetler, B., Weston, N., Kim, C., Morré, D. M., & Morré, D. J. (2009). Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase. Clinical Proteomics, 5(1), 46–51. https://doi.org/10.1007/s12014-008-9016-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free